Dasatinibobservational2016

Translating the effects of mTOR on secretory senescence.

Nature cell biology

confidence

Key findings

Review article on mTOR's role in controlling senescence-associated secretory phenotype; no clinical or biological endpoints related to dasatinib reported.

View source on PubMed (PMID 26419801) ↗

Sample size
Not applicable
Population
Not specified (review article)
Dosing
Not applicable
Duration
Not applicable
Route
Not applicable
Blinding
not_reported
Controls
not_reported
Drug class
senolytic
Full abstract

Cellular senescence is often accompanied by the production of secreted proteins that mediate the diverse effects of senescence on the tissue microenvironment. The mammalian target of rapamycin (mTOR), a master regulator of protein synthesis, is now shown to control the senescence-associated secretory phenotype by modulating gene transcription and mRNA translation and stabilization.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.